Compare Amphastar Pharmaceuticals Inc (AMPH) vs British American Tobacco PLC (BTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs British American Tobacco PLC — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while British American Tobacco PLC trades at $56.92 (market cap $122.96B). The key difference: British American Tobacco PLC is far larger — about 142.3× Amphastar Pharmaceuticals Inc's market cap, and British American Tobacco PLC pays a 5.85% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | BTI | |
|---|---|---|
Market Cap | $863.95M | $122.96B |
Sector | Health | Consumer Staples |
52-Week High | $30.81 | $66.70 |
52-Week Low | $16.87 | $50.39 |
Enterprise Value | $1.26B | $166.84B |
Dividend Yield | — | 5.85% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
BTI trades at $59.33, up 1.02% today, with a bearish technical signal but strong fundamentals including a P/E of 15.15, net income margin of 24.99%, and consistent earnings beats. Recent news highlights growth in next-generation products like Velo, though restructuring and regulatory pressures persist.
The outlook is mixed: valuation appears attractive with a 5%+ dividend yield, but declining operating cash flow and bearish technicals suggest near-term headwinds. Risks include regulatory scrutiny and combustible product declines, while analyst consensus leans bullish with 12 buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About British American Tobacco PLC
Following the acquisition of Reynolds American, British American Tobacco is neck-and-neck with Philip Morris International to be the largest listed global tobacco company--slightly larger than PMI on net revenue, but slightly smaller on total tobacco volume. British American's Global Drive Brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans, and it also owns Newport and Camel in the U.S. The firm also sells vapor e-cigarettes, including its Vype brand, heated tobacco, with Glo, as well as roll- your-own and smokeless tobacco products. The company holds 31% of ITC Limited, the leading Indian cigarette-maker.
Read more on BTI →
